Immunosuppressive therapy of proliferative glomerulonephritis in children. 1969

R E Urizar, and B Tinglof, and R McIntosh, and N Litman, and E Barnett, and J Wilkerson, and F Smith, and R L Vernier

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias

Related Publications

R E Urizar, and B Tinglof, and R McIntosh, and N Litman, and E Barnett, and J Wilkerson, and F Smith, and R L Vernier
January 1971, Lancet (London, England),
R E Urizar, and B Tinglof, and R McIntosh, and N Litman, and E Barnett, and J Wilkerson, and F Smith, and R L Vernier
November 1970, Lancet (London, England),
R E Urizar, and B Tinglof, and R McIntosh, and N Litman, and E Barnett, and J Wilkerson, and F Smith, and R L Vernier
September 1971, The New England journal of medicine,
R E Urizar, and B Tinglof, and R McIntosh, and N Litman, and E Barnett, and J Wilkerson, and F Smith, and R L Vernier
April 1976, Pediatriia,
R E Urizar, and B Tinglof, and R McIntosh, and N Litman, and E Barnett, and J Wilkerson, and F Smith, and R L Vernier
November 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation,
R E Urizar, and B Tinglof, and R McIntosh, and N Litman, and E Barnett, and J Wilkerson, and F Smith, and R L Vernier
October 1966, British medical journal,
R E Urizar, and B Tinglof, and R McIntosh, and N Litman, and E Barnett, and J Wilkerson, and F Smith, and R L Vernier
December 2018, BMJ case reports,
R E Urizar, and B Tinglof, and R McIntosh, and N Litman, and E Barnett, and J Wilkerson, and F Smith, and R L Vernier
October 1966, British medical journal,
R E Urizar, and B Tinglof, and R McIntosh, and N Litman, and E Barnett, and J Wilkerson, and F Smith, and R L Vernier
January 1972, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
R E Urizar, and B Tinglof, and R McIntosh, and N Litman, and E Barnett, and J Wilkerson, and F Smith, and R L Vernier
December 1982, The International journal of pediatric nephrology,
Copied contents to your clipboard!